These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Ocular involvement during prolonged treatment with neuroleptics]. Nouri A; Cuendet JF Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196 [No Abstract] [Full Text] [Related]
4. Ocular complications of phenothiazines. Mathalone MB Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613 [No Abstract] [Full Text] [Related]
5. Prognosis of eye complications caused by phenothiazines. Forrest FM; Snow HL Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560 [No Abstract] [Full Text] [Related]
6. Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy. Forrest FM; Snow HL; Erickson G; Geiter CW; Laxson GO Proc West Pharmacol Soc; 1966; 9():18-20. PubMed ID: 5958492 [No Abstract] [Full Text] [Related]
8. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study. Prien RF; DeLong SL; Cole JO; Levine J Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574 [No Abstract] [Full Text] [Related]
9. [Damage to eyes through conservative therapy]. Kleberger E Klin Monbl Augenheilkd; 1967; 151(6):777-801. PubMed ID: 4874408 [No Abstract] [Full Text] [Related]
10. Metabolic studies of chlorpromazine induced hyperpigmentation of the skin in psychiatric patients. Bolt AG; Forrest IS Agressologie; 1968; 9(2):201-7. PubMed ID: 5675487 [No Abstract] [Full Text] [Related]
11. Incidence and significance of chlorpromazine-induced eye changes. De Long SL Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741 [No Abstract] [Full Text] [Related]
12. Asymmetric anterior segment changes induced by chlorpromazine. Deluise VP; Flynn JT Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636 [TBL] [Abstract][Full Text] [Related]
13. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years). Goldman D Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486 [No Abstract] [Full Text] [Related]
14. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs]. Francesconi G; Di Tizio A; Cameo D Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709 [No Abstract] [Full Text] [Related]
15. Melanosis after prolonged chlorpromazine therapy. Robins AH S Afr Med J; 1975 Aug; 49(37):1521-4. PubMed ID: 1162531 [TBL] [Abstract][Full Text] [Related]